Equities
  • Price (ARS)19,133.50
  • Today's Change-49.00 / -0.26%
  • Shares traded316.00
  • 1 Year change+211.39%
  • Beta--
Data delayed at least 20 minutes, as of Mar 18 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ABBV:NYQ since
announced
Transaction
value
Cerevel Therapeutics Holdings IncAnnounced06 Dec 202306 Dec 2023Announced23.46%8.62bn
ImmunoGen IncDeal completed30 Nov 202330 Nov 2023Deal completed28.87%10.22bn
Data delayed at least 15 minutes, as of Mar 18 2024 20:10 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.